PharmaBiome
PrivateLast Round
Seed
Jul 8, 2020
Total Funding Raised
$2.45M
Company Overview
PharmaBiome operates in Healthcare & Life Sciences and is based in Schlieren. Its latest recorded funding round was a Seed round in July 2020.
PharmaBiome is a biotechnology company that develops a drug development platform for targeted microbiome therapeutics to treat diseases caused by functional deficiencies in the microbiome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PharmaBiome Comparables
Compare PharmaBiome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MarvelBiome Inc. | 87% | |
| ImmunoBiome Inc. | 84% | |
| mbiomics GmbH | 81% |
For institutional investors. Book with your work email.
PharmaBiome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 8, 2020 | ||||
| Grant | Apr 23, 2020 | ||||
| Accelerator | Jan 16, 2020 | ||||
| Grant | May 22, 2019 | ||||
| Grant | Dec 1, 2017 | ||||
Grant | Jun 14, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PharmaBiome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| W.A. de Vigier Foundation | Grant |
| BaseLaunch | Accelerator |
| Venture Kick | Grant |
| Zurcher Kantonalbank | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 1915% MoM, from 46 to 927.
- May 3, 2025
Monthly visitors grew 31% MoM, reaching 1K.
For institutional investors. Book with your work email.
PharmaBiome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PharmaBiome's valuation, stock price, and market status.
Is PharmaBiome a public or private company?
PharmaBiome is a private company.
What is the current stock price of PharmaBiome?
PharmaBiome is a private company, so its shares have no public market price. Caplight tracks PharmaBiome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PharmaBiome worth (valuation)?
Valuation information for PharmaBiome is not publicly available.
Can I buy PharmaBiome stock?
PharmaBiome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PharmaBiome's last funding round?
PharmaBiome's most recent funding round was Seed on July 8, 2020.
Who are the main investors in PharmaBiome?
Key investors in PharmaBiome include European Union's Horizon Research and Innovation program, W.A. de Vigier Foundation, BaseLaunch, Venture Kick, Zurcher Kantonalbank.
Will PharmaBiome IPO soon?
No public IPO plans have been announced for PharmaBiome.
How can I track PharmaBiome secondary market activity?
Caplight tracks bids, offers, and trades in PharmaBiome's shares on secondary markets.